Search results
Results from the WOW.Com Content Network
The National Health Regulatory Authority (NHRA) is an independent regulatory body established in 2010, under Law No. 38 of 2009, of the Kingdom of Bahrain. [1]Bahrain's hospitals, medical centres, pharmacies, physicians, surgeons, nurses, pharmacists, medical technicians and allied healthcare institutions and healthcare professionals must be registered with, and/or licensed, by NHRA.
Government-provided health care is free to Bahraini citizens and subsidized for non-Bahrainis. Healthcare expenditure accounted for 4.5% of Bahrain's GDP, according to the World Health Organization. Bahraini physicians and nurses form a majority of the country's workforce in the health sector, unlike neighbouring Gulf states. [2]
This is a list of hospitals in Bahrain. Hospitals in Bahrain can be classified into public hospitals (funded by the Ministry of Health or the Bahrain Defence Force ) and private hospitals. All hospitals are subject to inspection and accreditation by the National Health Regulatory Authority (NHRA), an independent regulatory body established in 2010.
A Bahrain government statement sent later Tuesday night to The Associated Press acknowledged that “a number of government agency websites have today been the target of malicious cyberattacks.”
The fourth Vaccine approved by Bahrain’s NHRA is Sputnik V COVID-19 vaccine [15] The National Health Regulatory Authority (NHRA) has also authorized, as the fifth vaccine, the emergency use of Janssen COVID-19 vaccine from Johnson and Johnson. [16] Bahrain became the first country in the world to approve this particular vaccine. [17]
Pages in category "Government ministries of Bahrain" ... Ministry of Finance & National Economy (Bahrain) ... Labour Market Regulatory Authority (Bahrain) M.
Bahrain's National Health Regulatory Authority approves the registration of the BBIBP-CorV vaccine developed by Sinopharm after Phase III clinical trials results showed an 86% efficacy rate. COVID-19 pandemic in Kuwait. Kuwait's Ministry of Health approves an Emergency Use Authorization of the Pfizer-BioNtech vaccine.
On 3 June 2021, the country's National Health Regulatory Authority approved Sotrovimab, a monoclonal antibody, for emergency use in mild to moderate COVID-19 patients. [85] In the same month, Bahrain's sovereign wealth fund Mumtalakat signed a memorandum of understanding with Russian Direct Investment Fund and Binnopharm to manufacture and ...